SPY is an exchange-traded fund (ETF) that aims to replicate the performance of the S&P 500 Index. The S&P 500 Index includes 500 of the largest publicly traded companies in the United States, representing a broad cross-section of the U.S. economy.
Metrics and analysis →ABBV
ABBV, or AbbVie Inc., is a global biopharmaceutical company that focuses on developing and marketing advanced therapies for complex diseases.
- Open
- 284.20
- High
- 290.23
- Low
- 284.00
- Prev close
- 283.54
- Volume
- 8M
- Avg vol 10
- 5M
Today · Market closed · opens Mon 9:30 AM
ABBV chart
Scroll or pinch to zoom, drag to pan, or use the buttons on the chart. About the price history
Technical analysis
Daily bars · last bar Nov 20, 2026 · close 286.20
No clear lean. 4 buy, 10 neutral and 4 sell across 18 signals. Stoch RSI sits in oversold territory. Trend strength is strong (ADX 25).
Trend
Momentum
Volatility
Volume
No clear lean. The close is above 13 of 24 averages and below 11. Price is below the short-term averages (5 to 20) and above the long-term ones (50 to 200). SMA 50 is above SMA 200 (279.00 vs 242.45).
| Period | SMA | EMA | WMA | WEMA |
|---|---|---|---|---|
| 5 | 288.62 | 287.82 | 286.89 | 289.28 |
| 10 | 291.48 | 289.42 | 289.78 | 288.74 |
| 20 | 290.44 | 288.54 | 290.67 | 283.31 |
| 50 | 279.00 | 280.10 | 285.23 | 267.62 |
| 100 | 266.75 | 267.37 | 274.65 | 251.70 |
| 200 | 242.45 | 251.72 | 256.63 | 238.12 |
Green: the close is above that average. Red: below it.
From the bar before the last one. Nearest classic support is the pivot at 283.16. Nearest resistance is R1 at 286.43.
| Level | Classic | Fibonacci | Camarilla | Floor | Woodie | DeMark |
|---|---|---|---|---|---|---|
| R3 | 295.50 | 289.33 | 285.24 | 292.60 | 296.09 | — |
| R2 | 289.33 | 286.97 | 284.67 | 289.33 | 291.07 | — |
| R1 | 286.43 | 285.51 | 284.11 | 286.43 | 289.92 | 284.79 |
| Pivot | 283.16 | 283.16 | 283.16 | 283.16 | 284.90 | 282.34 |
| S1 | 280.26 | 280.80 | 282.97 | 280.26 | 283.75 | 278.62 |
| S2 | 276.99 | 279.34 | 282.41 | 276.99 | 278.73 | — |
| S3 | 270.82 | 276.99 | 281.84 | 274.09 | 277.58 | — |
Patterns that formed on the last 5 bars, newest first.
A small body with shadows longer than the body on both sides.
Neither side won the bar. On its own it says little; after a strong move it warns the move is tiring.
A candle with a short body and short shadows: a quiet bar.
A small gain on little range; weak on its own.
A candle with a long body and short shadows.
Sellers controlled the bar.
How candlestick references usually rate the pattern. It is not a success rate measured on this ticker. About candle patterns
| Date | Open | High | Low | Close | Volume | Change |
|---|---|---|---|---|---|---|
| Nov 20, 2026 | 286.83 | 290.23 | 284.85 | 286.20 | 9M | −0.63 |
| Nov 19, 2026 | 285.00 | 286.05 | 279.88 | 283.54 | 5M | −1.46 |
| Nov 18, 2026 | 290.00 | 292.55 | 284.91 | 286.01 | 5M | −3.99 |
| Nov 17, 2026 | 291.50 | 294.06 | 291.00 | 292.82 | 4M | +1.32 |
| Nov 16, 2026 | 299.98 | 301.20 | 293.97 | 294.55 | 5M | −5.43 |
| Nov 13, 2026 | 296.58 | 297.25 | 293.56 | 295.03 | 3M | −1.55 |
| Nov 12, 2026 | 299.30 | 300.42 | 294.07 | 294.45 | 5M | −4.85 |
| Nov 11, 2026 | 291.36 | 295.46 | 289.73 | 294.98 | 3M | +3.62 |
| Nov 10, 2026 | 292.50 | 294.50 | 291.04 | 293.89 | 4M | +1.39 |
| Nov 9, 2026 | 293.84 | 294.57 | 289.59 | 293.30 | 6M | −0.54 |
| Nov 6, 2026 | 282.27 | 291.73 | 281.07 | 291.31 | 5M | +9.04 |
| Nov 5, 2026 | 298.74 | 302.93 | 287.71 | 288.24 | 8M | −10.50 |
| Nov 4, 2026 | 293.95 | 295.40 | 283.32 | 294.83 | 8M | +0.88 |
| Nov 3, 2026 | 288.69 | 291.32 | 284.70 | 286.00 | 5M | −2.69 |
| Nov 2, 2026 | 290.38 | 294.86 | 286.14 | 288.84 | 9M | −1.54 |
| Oct 30, 2026 | 292.00 | 298.74 | 291.01 | 294.89 | 7M | +2.89 |
| Oct 29, 2026 | 291.00 | 292.67 | 288.04 | 290.79 | 4M | −0.21 |
| Oct 28, 2026 | 282.93 | 288.80 | 281.23 | 285.99 | 3M | +3.06 |
| Oct 27, 2026 | 283.88 | 287.32 | 283.12 | 286.39 | 3M | +2.51 |
| Oct 26, 2026 | 287.05 | 289.59 | 285.18 | 286.74 | 5M | −0.31 |
| Oct 23, 2026 | 284.58 | 286.77 | 282.30 | 285.64 | 5M | +1.06 |
| Oct 22, 2026 | 284.57 | 285.76 | 278.01 | 285.19 | 6M | +0.62 |
| Oct 21, 2026 | 287.63 | 289.00 | 282.15 | 284.80 | 4M | −2.83 |
| Oct 20, 2026 | 286.90 | 290.98 | 285.00 | 289.08 | 5M | +2.18 |
| Oct 19, 2026 | 284.23 | 287.93 | 282.59 | 282.68 | 4M | −1.55 |
| Oct 16, 2026 | 283.61 | 286.64 | 282.96 | 285.42 | 6M | +1.81 |
| Oct 15, 2026 | 288.28 | 291.40 | 282.81 | 283.40 | 8M | −4.88 |
| Oct 14, 2026 | 277.00 | 285.40 | 275.97 | 283.48 | 6M | +6.48 |
| Oct 13, 2026 | 283.29 | 283.43 | 273.70 | 274.36 | 6M | −8.93 |
| Oct 12, 2026 | 277.65 | 281.30 | 276.01 | 281.12 | 6M | +3.47 |
Performance
Daily returns for Jan 1, 2026 – Nov 22, 2026 (YTD). About the returns · About the risk figures
1 month return
0.35%
Change in value over the past month.
3 month return
8.20%
Change in value over the last three months.
Max drawdown
16.43%
Largest fall from a peak to the low that followed.
Standard deviation
25.86%
How far daily returns stray from their average, annualised.
Sharpe ratio
1.09
Return above the risk-free rate per unit of volatility.
Calmar ratio
1.72
Annualised return against the maximum drawdown.
ABBV summary
Loading summary…
ABBV, answered
What are the key performance metrics for ABBV?
Key metrics include revenue growth, earnings per share (EPS), net income, and return on equity (ROE), which indicate the company’s financial health.
How does ABBV perform compared to its industry peers?
ABBV’s performance can be compared to other biopharmaceutical companies, focusing on product pipeline success, market share, and revenue growth.
How often does ABBV distribute dividends?
ABBV typically distributes dividends on a quarterly basis, providing a steady income stream for investors.
Are there any risks associated with investing in ABBV?
Yes, risks include competition in the biopharmaceutical space, regulatory challenges, and the potential for patent expirations on key products.
What is the dividend yield of ABBV?
As of the latest update, ABBV has a dividend yield of approximately 4.4%, reflecting its commitment to returning value to shareholders.
Can ABBV be used in a retirement account?
Yes, ABBV can be held in retirement accounts such as IRAs or 401(k)s, making it a suitable choice for long-term investment strategies.
What types of products does ABBV offer?
ABBV offers a range of pharmaceuticals, including treatments for immunological conditions, oncology therapies, and neuroscience-related medications.
How does ABBV handle dividends?
Dividends paid by ABBV can be reinvested to purchase additional shares or received in cash, depending on the investor’s preference.
What is the historical performance of ABBV?
Historically, ABBV has demonstrated strong performance, particularly driven by its flagship products in immunology and oncology.
How frequently is ABBV rebalanced?
ABBV does not undergo traditional rebalancing like an ETF, but it regularly assesses its product pipeline and strategic initiatives to optimize performance.
ABBV in the news
Top market assets
Discover our curated selection of top-performing exchange-traded funds (ETFs) that represent a diverse range of investment opportunities.
QQQ is an exchange-traded fund (ETF) that tracks the performance of the Nasdaq-100 Index. This index includes 100 of the largest non-financial companies listed on the Nasdaq Stock Market, primarily focusing on technology and innovation sectors.
Metrics and analysis →DIA is an exchange-traded fund (ETF) that aims to track the performance of the Dow Jones Industrial Average (DJIA). The DJIA is a stock market index consisting of 30 large, publicly traded companies in the United States, representing a broad range of industries.
Metrics and analysis →IWM is an exchange-traded fund (ETF) that seeks to track the performance of the Russell 2000 Index. The Russell 2000 Index measures the performance of the 2,000 smallest stocks in the Russell 3000 Index, representing a broad segment of small-cap U.S. companies.
Metrics and analysis →Empower Your ABBV Trading Now
Elevate your trading strategy with OHLCX Markets’s sophisticated tools for ABBV. Our system integrates cutting-edge technology and expert analysis to support your investment goals. Boost your investment success with us and explore the benefits of advanced trading now!
Disclaimers
The information displayed on this site is sourced from third-party providers and is believed to be reliable. OHLCX has not independently verified this data and does not guarantee its accuracy. Content is for educational and informational purposes only and is not financial or investment advice.
With any investment, your capital is at risk. Past performance is no guarantee of future results. Consult your provider's terms and privacy policies where applicable.
Prices, charts and every figure derived from them are delayed by at least 15 minutes and are provided for information only; we do not guarantee their accuracy or timeliness.
Securities products are: Not FDIC insured · Not bank guaranteed · May lose value
Trademarks and logos are the property of their respective owners and do not represent endorsements of any kind.